Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV

Alder,Susanna; Gustafsson,Sofia; Perinetti,Claudia; Mints,Miriam; Sundström,Karin; Andersson,Sonia

doi:10.3892/or.2015.3817

Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV

Authors:
- Susanna Alder
- Sofia Gustafsson
- Claudia Perinetti
- Miriam Mints
- Karin Sundström
- Sonia Andersson
View Affiliations

Affiliations: Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital Solna, 171 76 Stockholm, Sweden, Department of Obstetrics and Gynecology, Docent Extension National University of Cuyo, Regional Hospital Diego Paroissien, Godoy Cruz 475, Maipú, Mendoza, Argentina, Department of Laboratory Medicine, Karolinska Institutet and Hospital, 141 83 Stockholm, Sweden
Published online on: February 25, 2015 https://doi.org/10.3892/or.2015.3817
Pages: 2521-2528

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer is the second most common cancer among women in Argentina and the mortality rate is not declining despite opportunistic screening. Free-of-charge human papillomavirus (HPV) vaccination of 11-year-old girls was introduced in 2011. Parental acceptance of HPV vaccination is considered to be of great importance for HPV vaccine uptake. However, little is known regarding this factor in Argentina. The aim of the present study was to explore maternal HPV vaccination acceptance, willingness to pay for HPV vaccination and correlates of this willingness, awareness of HPV and HPV-associated disease and behaviors and attitudes associated with HPV vaccination acceptance. A total of 180 mothers of girls aged 9-15 years comprised this quantitative, cross-sectional, survey-based study, conducted at two hospitals in the Mendoza Province. Correlates of willingness to pay for HPV vaccination were obtained using multivariable logistic regression models. Maternal HPV vaccination acceptance was 90%, and 60% of mothers were willing to pay for HPV vaccination. Mothers who were gainfully employed and had a higher disposable household income were significantly more willing to pay for HPV vaccination [odds ratio (OR)=2.54, 95% confidence interval (CI) 1.01-6.38; OR=3.28, 95% CI 1.36‑7.94, respectively], as were mothers who were aware of cervical cancer prior to the study (OR=3.22, 95% CI 1.02-10.14). Only one in 10 mothers were informed that HPV vaccination does not offer complete protection against cervical cancer. In conclusion, the present study showed high maternal HPV vaccination acceptance, although acceptance decreased when vaccination was not free-of-charge. Continuous public education campaigns are needed to improve knowledge of HPV, HPV vaccines and HPV-associated disease.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
2	Cogliano VJ, Baan R, Straif K, et al: Preventable exposures associated with human cancers. J Natl Cancer Inst. 103:1827–1839. 2011. View Article : Google Scholar : PubMed/NCBI
3	Lu B, Kumar A, Castellsagué X and Giuliano AR: Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis. 11:132011. View Article : Google Scholar
4	Smith JS, Lindsay L, Hoots B, et al: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 121:621–632. 2007. View Article : Google Scholar : PubMed/NCBI
5	Malagón T, Drolet M, Boily MC, et al: Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 12:781–789. 2012. View Article : Google Scholar : PubMed/NCBI
6	Committee on Infectious D: HPV vaccine recommendations. Pediatrics. 129:602–605. 2012. View Article : Google Scholar : PubMed/NCBI
7	Tay SK: Cervical cancer in the human papillomavirus vaccination era. Curr Opin Obstet Gynecol. 24:3–7. 2012. View Article : Google Scholar
8	Sankaranarayanan R: HPV vaccination: the promise & problems. Indian J Med Res. 130:322–326. 2009.PubMed/NCBI
9	Kohli M, Ferko N, Martin A, et al: Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer. 96:143–150. 2007. View Article : Google Scholar
10	Brewer NT and Fazekas KI: Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 45:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
11	Dahlström LA, Tran TN, Lundholm C, Young C, Sundström K and Sparén P: Attitudes to HPV vaccination among parents of children aged 12–15 years - a population-based survey in Sweden. Int J Cancer. 126:500–507. 2010. View Article : Google Scholar
12	Allen JD, Coronado GD, Williams RS, et al: A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 28:4027–4037. 2010. View Article : Google Scholar : PubMed/NCBI
13	Arrossi S, Paolino M and Sankaranarayanan R: Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev Panam Salud Publica. 28:249–257. 2010. View Article : Google Scholar : PubMed/NCBI
14	Programa nacional de prevención de cáncer de cérvico-uterino. Datos Epidemiológicos. Minesterio de Salud; Buenos Aires, Argentina. 2011.
15	De Maio FG, Linetzky B and Ferrante D: Changes in the social gradients for Pap smears and mammograms in Argentina: evidence from the 2005 and 2009 National Risk Factor Surveys. Public Health. 126:821–826. 2012. View Article : Google Scholar : PubMed/NCBI
16	Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX and de Sanjosé S: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 202:1789–1799. 2010. View Article : Google Scholar : PubMed/NCBI
17	Badano I, Pedrozo RW, Ruiz Diaz LS, et al: Human papillomavirus (HPV) detection and Papanicolaou cytology in low-resource women in Posadas city, Misiones, Argentina. Rev Argent Microbiol. 43:263–267. 2011.
18	Chouhy D, D’Andrea RM, Iglesias M, et al: Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National Vaccination Program. J Med Virol. 85:655–666. 2013. View Article : Google Scholar : PubMed/NCBI
19	Deluca GD, Marin HM, Blanco NS, et al: Distribution of human papillomavirus genotypes in women with cervical alterations from north Argentina. Indian J Med Microbiol. 31:138–141. 2013.PubMed/NCBI
20	HPV vaccine in Argentina: a leap forward for girls’ and women’s health. World Health Organization (WHO); Geneva, Switzerland: 2013
21	Ciapponi A, Bardach A, Glujovsky D, Gibbons L and Picconi MA: Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One. 6:e254932011. View Article : Google Scholar : PubMed/NCBI
22	Colantonio L, Gómez JA, Demarteau N, Standaert B, Pichón-Rivière A and Augustovski F: Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Vaccine. 27:5519–5529. 2009. View Article : Google Scholar : PubMed/NCBI
23	Muñoz N, Franco EL, Herrero R, et al: Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 26(Suppl 11): L96–L107. 2008. View Article : Google Scholar : PubMed/NCBI
24	Arrossi S, Maceira V, Paolino M and Sankaranarayanan R: Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Vaccine. 30:2467–2474. 2012. View Article : Google Scholar : PubMed/NCBI
25	Bair RM, Mays RM, Sturm LA and Zimet GD: Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol. 21:329–334. 2008. View Article : Google Scholar : PubMed/NCBI
26	Dinh TA, Rosenthal SL, Doan ED, et al: Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health. 40:559–563. 2007. View Article : Google Scholar : PubMed/NCBI
27	Fazekas KI, Brewer NT and Smith JS: HPV vaccine acceptability in a rural Southern area. J Womens Health. 17:539–548. 2008. View Article : Google Scholar
28	Lazcano-Ponce E, Rivera L, Arillo-Santillán E, Salmerón J, Hernández-Avila M and Muñoz N: Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res. 32:243–247. 2001. View Article : Google Scholar : PubMed/NCBI
29	Lee FH, Paz-Soldan VA, Carcamo C and Garcia PJ: Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine. J Low Genit Tract Dis. 14:113–117. 2010. View Article : Google Scholar : PubMed/NCBI
30	Sundström K, Tran TN, Lundholm C, Young C, Sparén P and Dahlström LA: Acceptability of HPV vaccination among young adults aged 18–30 years - a population based survey in Sweden. Vaccine. 28:7492–7500. 2010. View Article : Google Scholar
31	Franco EL, Tsu V, Herrero R, et al: Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine. 26(Suppl 11): L88–L95. 2008. View Article : Google Scholar : PubMed/NCBI
32	Winkler JL, Wittet S, Bartolini RM, et al: Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine. 26(Suppl 11): L73–79. 2008. View Article : Google Scholar : PubMed/NCBI
33	Woodhall SC, Lehtinen M, Verho T, Huhtala H, Hokkanen M and Kosunen E: Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health. 40:466–469. 2007. View Article : Google Scholar : PubMed/NCBI
34	Holman DM, Benard V, Roland KB, Watson M, Liddon N and Stokley S: Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 168:76–82. 2014. View Article : Google Scholar
35	Mayhew A, Mullins TL, Ding L, et al: Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics. 133:404–411. 2014. View Article : Google Scholar : PubMed/NCBI
36	Ratanasiripong NT: Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern. J Sch Nurs. 30:456–463. 2014. View Article : Google Scholar : PubMed/NCBI
37	Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M and Ryan GL: Human papillomavirus vaccination and sexual behavior in young women. J Pediatr Adolesc Gynecol. 27:67–71. 2014. View Article : Google Scholar : PubMed/NCBI
38	Bednarczyk RA, Davis R, Ault K, Orenstein W and Omer SB: Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics. 130:798–805. 2012. View Article : Google Scholar : PubMed/NCBI
39	Forster AS, Marlow LA, Stephenson J, Wardle J and Waller J: Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine. 30:4939–4944. 2012. View Article : Google Scholar : PubMed/NCBI
40	Paolino M and Arrossi S: Women’s knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina. Women Health. 51:72–87. 2011. View Article : Google Scholar : PubMed/NCBI